The deadline for abstract submissions to the 19th International AIDS Conference (AIDS 2012) is fast approaching. The deadline is February 15th 2012.;

Read more >

The current HATIP article is the first in a two-part series on developing lab capacity – to support more active TB case finding. Active case finding is important to more quickly identify and diagnose cases of TB that might not otherwise have been diagnosed, and reduce the opportunity for these cases to spread TB in the communities.;

Read more >

REMEMBER stands for ‘Reducing Early Mortality and Early Morbidity by Empiric Tuberculosis (TB) Treatment Regimens’ and is a randomised controlled trial that is currently enrolling at the international ACTG sites in a number of resource-limited countries.;

Read more >

One of the recent editions of HATIP published in November 2011 addressed the extent to antiretroviral therapy (ART) could be used to reduce the burden of TB. There is no doubt that after the first few months of treatment ART dramatically decreases the risk of active TB in people living with advanced HIV disease — the question is how much of an effect it has on the risk of TB in HIV-positive people with higher CD4 cell counts.;

Read more >

“A nurse can initiate antiretroviral therapy (ART) and treat children with HIV, a common, manageable paediatric condition,” said Sister Martha Mashele, who shared how she overcame her fears and empowered herself to initiate ART and thus, save the lives of children with HIV, before a crowd of doctors, nurses, pharmacists and counsellors gathered at the Paediatric AIDS Treatment for Africa Forum held in Gaborone, Botswana in November 2011.;

Read more >